今日药学

2021, v.31(01) 77-80

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

基于药品采购金额分析我省第一批国家重点监控药品的监管效果
Evaluating the Effect Regulation to the First National Key Monitoring Drugs based on Amount of Drug Procurement in Guangdong Province

柯涌波;郑志华;刘宇恒;曾泗宇;
KE Yongbo;ZHENG Zhihua;LIU Yuheng;ZENG Siyu;GuangDong Pharmaceutical Association;Guangdong Second Provincial General Hospital;

摘要(Abstract):

目的从药品采购金额角度探讨实施国家监管对我省第一批国家重点监控药品临床应用的影响。方法统计广东省二、三级医疗机构2018年上半年、2018年下半年、2019年上半年和2019年下半年第一批国家重点监控药品的采购金额,并计算采购金额占比。结果加强重点监控药品监管显著降低了我省二、三级医疗机构第一批国家重点监控药品采购金额占比,其中神经节苷脂等10个品种采购金额占比呈明显下降趋势,小牛血清去蛋白等5个品种采购金额占比呈一定程度的下降趋势,而脑蛋白水解物、长春西汀和马来酸桂哌齐特3个品种采购金额占比则变化不大。结论实施国家监管能显著降低第一批国家重点监控药品的采购金额占比,从而促进其临床合理应用,但目前仍有必要进一步强化管理。
OBJECTIVE To investigate the role of the first national key monitoring drugs( NKMDs) based on the amount of money for drug purchase. METHODS The amount of purchasing the first NKMDs was counted from the secondary and third medical institutions in the first half and the latter half of 2018 and 2019,and the ratio between amount of the first NKDMs purchase to the sum of money for drug purchase was calculated. RESULTS Strengthen the regulation to NKMDs could decrease the ratio between the amount of the first NKDMs purchasing in the secondary and third medical institutions of Guangdong province to the sum of money for drug purchase significantly. Among these drugs,the ratios exhibited significantly trending downward in 10 drugs( such as ganglioside)and a certain diminishing trend in 5 drugs( such as deproteinised calf blood). but no marked change in cerebroprotein hydrolysate,vinpocetine,and cinepazide maleate. CONCLUSION National special regulation can significantly decline the ratio between amount of the first NKDMs purchase to the sum of money for drug purchase,thereby promoting their rational clinic application. However,in the precent it still requires further national special regulation.

关键词(KeyWords): 药品采购金额;国家重点监控药品;国家监管
amount of drug procurement;national key monitoring drugs;national special regulation

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 柯涌波;郑志华;刘宇恒;曾泗宇;
KE Yongbo;ZHENG Zhihua;LIU Yuheng;ZENG Siyu;GuangDong Pharmaceutical Association;Guangdong Second Provincial General Hospital;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享